Is There Hope for Sarepta?
July 14, 2016 at 12:50 PM EDT
An FDA decision another drug maker’s Duchenne muscular dystrophy therapy is spelling bad news for Sarepta Therapeutics ( SRPT ).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.